News
-
-
-
COMMUNIQUÉ DE PRESSE
CORRECTING AND REPLACING: Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Annual mRNA-based Therapeutics Summit
Applied DNA Sciences presents Linea IVT platform as a solution for improved mRNA production at 4th Annual mRNA-based Therapeutics Summit. The platform reduces dsRNA contamination -
-
-
COMMUNIQUÉ DE PRESSE
Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Presentation Annual mRNA-based Therapeutics Summit
Applied DNA Sciences, Inc. will present Linea™ IVT platform at 4th Annual mRNA-based Therapeutics Summit to reduce dsRNA contamination in mRNA production, enabling faster and more efficient workflows -
-
-
COMMUNIQUÉ DE PRESSE
Applied DNA Enters into Multi-Year Commercialization Agreement with Indus Group for Large-Scale Implementation of CertainT Cotton Traceability
Applied DNA Sciences announces a five-year license & commercialization agreement with Indus Group for its CertainT® traceability platform. Indus to utilize platform for cotton-based products
